Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofia Ananiadou

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Contemporary Clinical Trials|February 11, 2019
Non-invAsive VentIlation for early General wArd respiraTory failurE (NAVIGATE): A multicenter randomized controlled study. Protocol and statistical analysis planLuca Cabrini, Claudia Brusasco, Agostino Roasio, et al.
JAMA|June 16, 2023
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical TrialGiacomo Monti, Nikola Bradic, Matteo Marzaroli, et al.
Contemporary Clinical Trials|March 8, 2021
Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and designGiacomo Monti, Carola Galbiati, Fabio Toffoletto, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Contemporary Clinical Trials|February 11, 2019
Non-invAsive VentIlation for early General wArd respiraTory failurE (NAVIGATE): A multicenter randomized controlled study. Protocol and statistical analysis planLuca Cabrini, Claudia Brusasco, Agostino Roasio, et al.
JAMA|June 16, 2023
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical TrialGiacomo Monti, Nikola Bradic, Matteo Marzaroli, et al.
Contemporary Clinical Trials|March 8, 2021
Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and designGiacomo Monti, Carola Galbiati, Fabio Toffoletto, et al.
Pageof 1